Egyptian International Pharmaceuticals EIPICO

مادة اعلانية

Latest Update: 6 Apr 2025 16:27 Abu Dhabi Time.

Market Status: Closed

PHAR

Egyptian International Pharmaceuticals EIPICO

50.00

EGP

-0.490

-0.97%

Open

50.49

Prev Close

50.49

PX_VOLUME

377,865

MARKET CAP (M)

DAY RANGE

48.33 - 50.20

52 WEEKS

32.23 - 54.70

Stock Statistics

Yearly Change

17.15%

Listed Shares (Million)

168.76

Earnings Multiple

6.85

Average 30-day trading volume

400,117.33

Price-to-book ratio

1.61

Earnings Per Share

7.37

Previous Dividend Distribution

1.90

Dividend Yield

3.96%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		2,138.54	2,069.94	1,878.96	1,503.10	1,550.58	1,411.12
Gross Profit		845.57	924.33	957.12	679.15	633.60	609.06
Operating Income		253.80	495.58	550.60	288.63	380.22	353.05
Profit Margin		5.51	10.19	9.62	40.51	11.81	9.82

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		7,590.55	5,231.67	3,955.16	3,408.80	2,909.77
Gross Profit		3,406.16	2,335.32	1,653.19	1,491.68	1,215.68
Operating Income		1,588.61	1,312.20	767.92	825.84	595.10
Profit Margin		14.74	16.01	16.55	14.59	17.02

Balance Sheet

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		15,372.96	14,704.19	13,901.66	13,116.03	9,978.78	9,742.75
Total Liabilities		10,715.37	9,908.59	9,305.30	8,642.93	5,717.98	5,661.10
Total Equity		4,657.59	4,795.61	4,596.35	4,473.10	4,260.80	4,081.64

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		15,372.96	9,978.78	6,773.91	5,234.89	5,032.61
Total Liabilities		10,715.37	5,717.98	3,531.52	2,261.42	2,185.79
Total Equity		4,657.59	4,260.80	3,242.39	2,973.47	2,846.82

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

PHAR

Egyptian International Pharmaceuticals EIPICO

المصرية الدولية للصناعات الدوائية